Neuigkeiten zu US und internationalem Patentrecht von den Webseiten und Bitte beachten Sie, dass die hier gezeigten Informationen automatisch und ohne vorherige Prüfung von den genannten externen Anbietern geladen und angezeigt werden. Entsprechend kann für Vollständigkeit und Richtigkeit dieser sowie der etwaig verlinkten Informationen keine Gewähr oder Haftung übernommen werden.

Sponsored by MBHB LLP

Patent – Patently-O
America's leading patent law blog
Are you Smarter than a 2L?: Patent Law Exam
17/12 - 2017 Patent
My patent law class at Mizzou focuses on practical aspects of drafting claims, forming rejections, and arguing motions.  However, the students also take a short final exam that counts for about 30% of their grade.  The following is this year’s exam – DC.  Introduction: On her drive from Florida to Mizzou in June 2017, Dean Lidsky struggled to […]
We are all FUCT
15/12 - 2017 Patent
In re Bruneti (Fed. Cir. 2017) The Federal Circuit has ruled that trademark law’s bar against registering immoral or scandalous marks is an unconstitutional restriction of free speech.  Thus, on appeal the court has reversed the TTAB’s holding that Bruneti’s mark FUCT is unregistrable. (FUCT Clothing Store). This decision follows the Supreme Court’s recent decision in Matal v. […]
Andrei Iancu
15/12 - 2017 Patent
The Senate Judiciary Committee has approved President Trump’s nomination of Andrei Iancu as USPTO Director and Under Secretary of Commerce (unanimous consent). The nomination now moves to the Senate Floor where no roadblocks are expected other than the difficulty in having the Senate focus on any particular item. Iancu was born in 1968 in Romania Bucharest […]
Amgen on Remand: BPCIA Preempts State Unfair Competition and Conversion Law
14/12 - 2017 Patent
by Dennis Crouch Amgen v. Sandoz (Fed. Cir. 2017) [AmgenSandoz Fed Cir Decision Dec 2017] The BPCIA (Biologics Price Competition and Innovation Act of 2009) is designed to promote innovation in biologic drug treatments while also facilitating a strong follow-on biosimilar (generic) market.  At a very high level, BPCIA runs parallel to the provisions of the Hatch-Waxman […]
¿Does Secret Prior Art Apply to the Obviousness Analysis?
14/12 - 2017 Patent
by Dennis Crouch It is not clear from ,u reading the AIA revisions that “secret prior art” (102(b)(2) prior art) continues to qualify as prior art for the obviousness analysis.  The obviousness provision (Section 103) refers to prior art in the context of what would be known “before the effective filing date of the claimed […]
RecogniCorp: Can Data Processing be Patented?
13/12 - 2017 Patent
In RecogniCorp, LLC v. Nintendo Co., Ltd., petitioner-patentee RecogniCorp has asked the Supreme Court to take a fresh look at its eligibility doctrines with the following two questions presented: Whether computer-implemented inventions that provide specific improvements to existing technological processes for encoding or decoding data are patent-eligible under the first step of the Alice test, […]
AI Patent Quality
12/12 - 2017 Patent
Ji-Yong (David) Chung is a partner at Snyder, Clark, Lesch & Chung.
Federal Circuit Ducks Major Prior Art Analysis: Affirms Weird PTAB Prior Art Holding
12/12 - 2017 Patent
by Dennis Crouch Ariosa (Roche) v. Illumina (Fed. Cir. 2017) Interesting decision here on two different fronts: Reviewability of Ex Parte Reexamination Termination Decision; and Priority Prior Art Date for Patent Applications. The dispute focuses on Illumina’s U.S. Patent No. 7,955,794 and arose after the inventors left Ariosa to form competitor Illumina. License Arbitration Clause Ineffective Because it Excluded […]
Issue Preclusion for Patent Applicants
8/12 - 2017 Patent
by Dennis Crouch Blaise Mouttet is seeking a patent on his “Crossbar Arithmetic and Summation Processor.”  The invention is interesting because it is actually processor design. [17-2077.Opinion.12-6-2017] Back in 2012, the Federal Circuit affirmed the PTO obviousness rejection of his pending claims in a parent application.  Following that negative outcome, Mouttet amended the pending CIP application to include […]
Purpose of Claim Construction: Construing Ordinary Terms
8/12 - 2017 Patent
by Dennis Crouch The Federal Circuit has denied the NobelBiz petition for en banc rehearing on questions of patent claim construction. Namely, the focus here is whether a district court is required to issue a claim construction beyond “plain and ordinary meaning” any time a litigant asserts a “dispute.”  The majority approach means that in […]


All RSS Feeds and contents displayed on this website contain material derived from, or supplied by, various news providing services and other sources and may be protected by international copyright and trademark laws. Dienwiebel Transatlantic IP (DTIP) processes all information automatically using automated software without any human intervention or screening. Therefore, DTIP is not responsible for any RSS Feed and its content and cannot guarantee the accuracy of any of the information contained therein; neither does the presence of any RSS Feed and its content indicate endorsement or recommendation by DTIP. DTIP may modify, suspend or discontinue any aspect of the RSS Feed at any time. DTIP may also impose limits on certain features and services or restrict your access to parts or all of the RSS Feeds without notice or liability of any kind. DTIP, its related entities, directors, employees, advisors or agents accept no liability for any loss or damage arising directly or indirectly from action taken or not taken in reliance of any RSS Feed and its content.